Celcuity CELC Stock
Celcuity Price Chart
Celcuity CELC Financial and Trading Overview
| Celcuity stock price | 71.25 USD |
| Previous Close | 72.1 USD |
| Open | 72.49 USD |
| Bid | 74.44 USD x 100 |
| Ask | 89.45 USD x 200 |
| Day's Range | 69 - 74.6 USD |
| 52 Week Range | 45.03 - 151.02 USD |
| Volume | 1.28M USD |
| Avg. Volume | 1.18M USD |
| Market Cap | 3.6B USD |
| Beta (5Y Monthly) | 0.108 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.17 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 156.91 USD |
CELC Valuation Measures
| Enterprise Value | 3.6B USD |
| Trailing P/E | N/A |
| Forward P/E | -920.25006 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -17.281 |
Trading Information
Celcuity Stock Price History
| Beta (5Y Monthly) | 0.108 |
| 52-Week Change | 46.50% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 151.02 USD |
| 52 Week Low | 45.03 USD |
| 50-Day Moving Average | 87.26 USD |
| 200-Day Moving Average | 104.43 USD |
CELC Share Statistics
| Avg. Volume (3 month) | 1.18M USD |
| Avg. Daily Volume (10-Days) | 1.08M USD |
| Shares Outstanding | 48.93M |
| Float | 29.72M |
| Short Ratio | 14.14 |
| % Held by Insiders | 10.22% |
| % Held by Institutions | 110.31% |
| Shares Short | 11.36M |
| Short % of Float | 34.82% |
| Short % of Shares Outstanding | 23.21% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.77% |
| Return on Equity (ttm) | -1433.70% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -208479008 USD |
| Net Income Avi to Common (ttm) | -226482000 USD |
| Diluted EPS (ttm) | -4.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 754.04M USD |
| Total Cash Per Share (mrq) | 15.41 USD |
| Total Debt (mrq) | 754.39M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.931 |
| Book Value Per Share (mrq) | -0.261 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -191706000 USD |
| Levered Free Cash Flow (ttm) | -72001000 USD |
Profile of Celcuity
| Country | United States |
| State | MN |
| City | Minneapolis |
| Address | 2800 Campus Drive |
| ZIP | 55441 |
| Phone | (763) 392-0123 |
| Website | https://www.celcuity.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 155 |
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
Q&A For Celcuity Stock
What is a current CELC stock price?
Celcuity CELC stock price today per share is 71.25 USD.
How to purchase Celcuity stock?
You can buy CELC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Celcuity?
The stock symbol or ticker of Celcuity is CELC.
Which industry does the Celcuity company belong to?
The Celcuity industry is Biotechnology.
How many shares does Celcuity have in circulation?
The max supply of Celcuity shares is 48.93M.
What is Celcuity Price to Earnings Ratio (PE Ratio)?
Celcuity PE Ratio is now.
What was Celcuity earnings per share over the trailing 12 months (TTM)?
Celcuity EPS is -4.17 USD over the trailing 12 months.
Which sector does the Celcuity company belong to?
The Celcuity sector is Healthcare.
Celcuity CELC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27599.89 USD — |
+0.45
|
7.66B USD — | 27592.56 USD — | 27722.75 USD — | — - | 7.66B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
127.9 USD — |
-1.07
|
— — | 127.87 USD — | 130.12 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1292.45 USD — |
-2.09
|
— — | 1285.97 USD — | 1330.32 USD — | — - | — — |
- {{ link.label }} {{link}}
